Hybrid Coronary Percutaneous Treatment with Metallic Stents and Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-Years Results from the GABI-R Registry

The limitations of the first-generation everolimus-eluting coronary bioresorbable vascular scaffolds (BVS) have been demonstrated in several randomized controlled trials. Little data are available regarding the outcomes of patients receiving hybrid stenting with both BVS and drug-eluting stents (DES...

Descripción completa

Detalles Bibliográficos
Autores principales: Gori, Tommaso, Achenbach, Stephan, Riemer, Thomas, Mehilli, Julinda, Nef, Holger M., Naber, Christoph, Richardt, Gert, Wöhrle, Jochen, Zahn, Ralf, Neumann, Till, Kastner, Johannes, Schmermund, Axel, Hamm, Christian, Münzel, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617525/
https://www.ncbi.nlm.nih.gov/pubmed/31151213
http://dx.doi.org/10.3390/jcm8060767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617525/
https://www.ncbi.nlm.nih.gov/pubmed/31151213
http://dx.doi.org/10.3390/jcm8060767

Ejemplares similares